REPLY
Reply announced today that it has implemented a Quantum Inspired Algorithm, that can be used on both Quantum and traditional computers, for Enel , one of the leading global operators in the electricity and renewable energy production sector. The innovative solution allows Enel to quickly identify the optimal allocation of maintenance activities for operating units distributed across the areas where it operates.
For Enel, which boasts a presence in over 30 countries around the world, a network of over 2.2 million kilometres and 74 million end users, it is essential to coordinate the crews and the allocation and planning of the objectives of the operating units scattered throughout the various territories to guarantee the highest level of service for its customers. Hence the need for operational planning that is as efficient as possible.
The solution developed by Reply is based on the QUBO (Quadratic Unconstrained Binary Optimisation ) mathematical model and can be performed effectively by quantum hardware, known as Quantum Processing Units or QPUs , as well as by classical hardware, known as Graphics Processing Units or GPUs .
Extracting the maximum potential of the GPUs was possible thanks to the MegaQUBO accelerator, a software solution developed by Data Reply to speed up the implementation of Quantum Inspired Optimisation projects . MegaQUBO is a solution certified by Amazon Web Services for use on the AWS Cloud, through the “FTR - Foundational Technical Review” process, which ensures that the software adheres to AWS architectural best practices.
In addition to identifying the optimal allocation of activities, the algorithm created for Enel is also able to calculate the optimal travel routes to reach work destinations, minimising travel times and distances and maximising the time available for actual maintenance work. This leads to a significant increase in productivity and a substantial reduction in operating costs, as well as the corresponding environmental impact .
“Quantum computing makes it possible to solve challenges considered insurmountable until just a few years ago” comments Filippo Rizzante, CTO of Reply . “As we were able to successfully demonstrate based on our experience with Enel, the use of quantum algorithms to solve optimisation problems allows us to obtain significant benefits, not only in the quality of the results, but also in the reduction of processing times. At Reply, we are thus closely exploring different areas in which we can exploit the potential of quantum computing to obtain insights from extremely large and constantly updated databases.”
“The need to implement optimisation strategies on increasingly large territorial areas has correspondingly enhanced the complexity of the problem, to the point that a new and innovative approach was needed”, explains Fabio Veronese, Head of Infrastructure & Networks Digital Hub at ENEL . “The Quantum Inspired approach implemented together with Reply has made it possible to achieve significant and concrete results in the field, and is applicable to both known problems, as well as to new business contexts.”
Reply
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on the new communication channels and digital media. Through its network of highly specialised companies, Reply partners with major European corporations in the telecoms and media, industry and services, banking and insurance, and public administration sectors, to devise and develop business models built on the new paradigms of artificial intelligence, big data, cloud computing, digital media, and the Internet of Things. Reply’s services include: Consulting, Systems Integration, and Digital Services. www.reply.com
Data Reply
Data Reply is the Reply group company that specialises in Big Data Analytics, Artificial Intelligence, and Quantum Computing. Thanks to multidisciplinary teams of specialists in Big Data Engineering, Data Science, Intelligent Process Automation, and Quantum & Accelerated Computing, Data Reply supports companies operating in different industrial sectors in their process optimisation journey, through the design and implementation of advanced Quantum Computing solutions and Machine Learning and Artificial Intelligence models. www.data.reply.com
Enel
Enel is the largest European utility by ordinary EBITDA and is present in over 30 countries worldwide, producing energy with around 88 GW of installed capacity. Enel distributes electricity through a network of over 2.2 million kilometres, and with approximately 74 million corporate and domestic end users worldwide, the Group boasts the largest customer base among European competitors. Within the Enel Group, Enel Green Power is the largest private operator in the renewable energy sector in the world, with a managed capacity of over 46 GW from wind, solar, geothermal and hydroelectric plants in Europe, the Americas, Africa, Asia and Oceania. Enel X, Enel’s global advanced energy services business line, is a world leader in demand response, with a total capacity of over 6.3 GW managed globally. The company has installed 110 MW of storage capacity and, in the electric mobility sector, over 100,000 charging points for public and private electric vehicles worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005064/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
